Uploaded on Jan 21, 2022
Tuberculosis (TB) has been declared as a health emergency due to emergence of resistant strains of M. tuberculosis, multidrug resistant (MDR), extensively drug-resistant (XDR) TB strains and totally drug-resistant tuberculosis (TDR-TB) reported recently in some parts of the world. Therefore, the current situation necessitates developing new antitubercular agents acting on novel targets for effectively controlling TB.
Paper TSC June 2021
Research paper of Dr. Trupti Chitre
Title: Exploring Pyrimidine Pharmacophore as Thymidine Monophosphate Kinase Inhibitors for
Antitubercular Activity: A Review
Authors: Trupti Sameer Chitre*, Kalyani Dhirendra Asgaonkar , Shital Manoj Patil , Muthu
Kumaradoss Kathiravan and Subhash Balkrishna Padhye
Journal Details: Current Topics in Medicinal Chemistry, 2016, 16, 3211-3223
Publisher: Bentham Science Publishers
Description:
Tuberculosis (TB) has been declared as a health emergency due to emergence of resistant strains of
M. tuberculosis, multidrug resistant (MDR), extensively drug resistant (XDR) TB strains and totally
drug resistant tuberculosis (TDR-TB) reported recently in some parts of the world. Therefore, the
current situation necessitates developing new antitubercular agents acting on novel targets for
effectively controlling TB. Thymidine Monophosphate Kinase (TMPKmt) enzyme is one such target,
which is being explored. This review focuses on Structure Activity Relationship studies (SARs) and
computational studies of various nucleotide and nucleoside derivatives of pyrimidine analogs
reported as TMPKmt inhibitors.
Photographs :
Comments